In Vivo Real-time Detection of Circulating Melanoma Cells
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 to 80 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Age 18 to 80 years * Histological documented diagnosis of melanoma * Signed informed consent form approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB) * Must be able to sit still for 90 minutes Exclusion Criteria: * Active infection * Current and significant medical or surgical condition as determined by the Investigator * Diagnosis or evidence of organic brain syndrome * Pregnancy or breastfeeding
About the study
The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.
Sponsor: University of Arkansas · Participants: 75 · Started: 2013-02
Contact the study team
- Jumin Sunde, MD · Phone: 501-526-6990
- Daniel Dunham · Phone: 5016868274
Official record on ClinicalTrials.gov — NCT01776905
Locations in the U.S.
| Arkansas | University of Arkansas for Medical Sciences, Little Rock |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.